[Toxoplasmosis]

Area of Science:

• Neuroscience
• Infectious Diseases
• Parasitology

Background:

• Toxoplasmic encephalitis (TE) is a serious opportunistic infection impacting the central nervous system.
• It primarily affects individuals with severe cellular immunodeficiency, such as those with acquired immunodeficiency syndrome (AIDS) and low CD4 counts.
• Reactivation of latent Toxoplasma gondii cysts in the brain causes TE.

Purpose of the Study:

• To review the epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment of Toxoplasmic encephalitis.
• To highlight diagnostic challenges, particularly differentiating TE from primary central nervous system lymphoma.
• To emphasize the importance of early diagnosis and treatment for improved patient outcomes.

Main Methods:

• Review of existing literature on Toxoplasmic encephalitis.
• Analysis of diagnostic criteria, including serologic testing, cerebrospinal fluid analysis, and neuroimaging.
• Evaluation of current therapeutic strategies and maintenance protocols.

Main Results:

• TE presents with symptoms like headache, fever, neurological deficits, seizures, and altered mental status.
• Neuroimaging may show ring-enhancing lesions, complicating differential diagnosis with CNS lymphoma.
• Diagnosis is confirmed through serology, PCR in CSF, and characteristic MRI findings like the eccentric target sign.

Conclusions:

• Early diagnosis of TE is critical for effective management.
• The standard first-line treatment involves pyrimethamine and sulfadiazine, with maintenance therapy recommended.
• Prompt initiation of appropriate therapy significantly improves patient prognosis in cases of Toxoplasmic encephalitis.